Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other
companies in this sector in the United States:
sales of $20.85 billion
of which 33%
Eli Lilly and Company
of which 38%
was Endocrinology), and
of which 100%
Teva Pharmaceutical Industries Limited reported sales of $21.90 billion
December of 2016.
increase of 11.5%
versus 2015, when the company's sales were $19.65 billion.
Sales of Generic Madicines saw an increase
that was more than double the company's growth rate: sales were up
25.6% in 2016, from
$9.55 billion to $11.99 billion.
Not all segments of Teva Pharmaceutical Industries Limited experienced an increase in sales in 2016:
sales of Other fell 29.9% to $1.24 billion.